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Acquired Immunodeficiency Syndrome and the Risk
of Stroke
John W. Cole, MD; Amelia N. Pinto, MD; J. Richard Hebel, PhD; David W. Buchholz, MD;
Christopher J. Earley, MD, PhD; Constance J. Johnson, MD; Richard F. Macko, MD;
Thomas R. Price, MD; Michael A. Sloan, MD; Barney J. Stern, MD; Robert J. Wityk, MD;
Marcella A. Wozniak, MD, PhD; Steven J. Kittner, MD, MPH
Background and Purpose—Although acquired immunodeficiency syndrome (AIDS) is thought to increase the risk of
stroke, few data exist to quantify this risk. This is the first population-based study to quantify the AIDS-associated risk
of stroke.
Methods—We identified all incident ischemic stroke (IS) and intracerebral hemorrhage (ICH) cases among young adults
15 to 44 years of age in central Maryland and Washington, DC, who were discharged from any of the 46 hospitals in
the study area in 1988 and 1991. Using data from the medical records, 2 neurologists reviewed each case to confirm the
diagnosis. Cases of AIDS among these patients with stroke were defined using Centers for Disease Control and
Prevention criteria (1987). The number of cases of AIDS in the central Maryland and Washington population during
1988 and 1991 was determined from regional health departments working with the Centers for Disease Control and
Prevention. Poisson regression was used to estimate the age-, race-, and sex-adjusted relative risk of stroke associated
with AIDS.
Results—There were 385 IS cases (6 with AIDS) and 171 ICH cases (6 with AIDS). The incidences of IS and ICH among
persons with AIDS were both 0.2% per year. AIDS conferred an adjusted relative risk of 13.7 (95% confidence interval
[CI], 6.1 to 30.8) for IS and 25.5 (95% CI, 11.2 to 58.0) for ICH. After exclusion of 5 cases of stroke in AIDS patients
in whom other potential causes were identified, AIDS patients continued to have an increased risk of stroke with an
adjusted relative risk of 9.1 (95% CI, 3.4 to 24.6) for IS and 12.7 (95% CI, 4.0 to 40.0) for ICH.
Conclusions—This population-based study found that AIDS is strongly associated with both IS and ICH. (Stroke. 2004;
35:51-56.)
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Stroke has often been reported as a complication ofacquired immunodeficiency syndrome (AIDS). However,
few data exist to quantify the risk of AIDS-associated stroke.
Furthermore, most existing studies fail to distinguish between
strokes associated with medical conditions known to be
associated with HIV infection such as lymphoma, opportu-
nistic infections, and endocarditis and strokes resulting from
an as-yet-undetermined HIV-related process.1,2 Several pos-
sible mechanisms have been hypothesized to account for
stroke in association with AIDS, including a prothrombotic
state2 or a covert HIV-induced vasculopathy.3,4 Currently,
there are no reported population-based studies regarding the
association of AIDS with stroke; therefore, the actual mag-
nitude of AIDS-associated stroke risk remains in question. To
address these issues, we report the first study to quantify the
overall AIDS-associated risk of stroke within a defined
population. In addition, the analysis was repeated excluding
strokes thought to be a result of AIDS-associated medical
conditions to approximate the risk of stroke associated solely
with AIDS.
Methods
Identification of Individuals With Stroke
The Baltimore-Washington Cooperative Young Stroke Study (BW-
CYSS) is a regional, hospital-based registry initiated to study the
incidence and cause of stroke in young adults.5 The study region
encompasses Baltimore; Washington, DC; and 5 central Maryland
counties (Anne Arundel, Baltimore, Howard, Montgomery, and
Prince Georges). The total population of this region in 1990 was
3 935 910. The population that was 15 to 44 years of age was
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2 077 825; 58% of this group were white, 36% were black, 3% were
Asian, and 3% were from other racial and ethnic groups.
All 44 acute-care hospitals and both rehabilitation hospitals in this
region participated in the study. Institutional Review Board approval
was obtained at all participating institutions. Because of referral
patterns, it was considered unlikely that persons who lived in the
study region would be admitted to hospitals outside this area. Data
were available for 1988 and 1991, during which there were 2470
hospital discharges of persons 15 to 44 years of age with a primary
or secondary diagnosis reflecting a possible cerebral infarction (1988
and 1991) or intracerebral hemorrhage (ICH; 1991) (International
Classification of Diseases, 9th revision [ICD-9], codes 431.00
through 438.00, indicating cerebrovascular disease other than sub-
arachnoid hemorrhage; 671.50 through 671.54, indicating cerebral
venous thrombosis; and 674.00 through 674.04, indicating cerebro-
vascular complications of the puerperium). Of these cases, medical
records from 2309 (93%) were available for review by a nurse who
had experience in caring for patients with stroke and who had been
trained in the study procedures. From our case-control studies in the
same population using both discharge surveillance and direct referral
from regional neurologists, we estimate that 3% of cases are not
hospitalized.
The abstracting process yielded a narrative summary for each
patient that described past strokes and episodes of transient ischemic
attacks, neurological symptoms and signs at presentation, and their
evolution. In addition, the data recorded included demographic
characteristics; risk factors (for ICH, only the 1991 data included this
information); laboratory data, including the results of neuroimaging;
all ICD-9 codes at discharge; and autopsy data if available.
The abstracted information on each possible acute stroke was
reviewed by 2 neurologists who classified the event as a cerebral
infarction, ICH, or other medical condition. Stroke was defined
according to the criteria of the World Health Organization as a focal
neurological deficit of sudden onset with symptoms lasting 24
hours or leading to death before this period with no other cause than
cerebrovascular disease.6 This definition therefore excludes patients
with subarachnoid hemorrhage and transient ischemic attack. The
definitions of cerebral infarction and ICH were based on the criteria
of the Stroke Data Bank of the National Institute of Neurological
Disorders and Stroke.7 We chose to include strokes resulting from
cerebral venous thrombosis in the category of cerebral infarction
because central venous thrombosis is often misdiagnosed and be-
cause any unrecognized cases would be included as cerebral infarc-
tions. Probable and possible causes were also assigned during the
review process.8 Disagreements between the neurologists were
resolved by consensus in meetings with a third neurologist. Strokes
that occurred as immediate consequences of trauma were excluded.
Cerebral infarction associated with subarachnoid hemorrhage was
also excluded. Only first stroke occurring in persons who lived in the
study region were included in the present analysis.
Identification of Stroke Cases With AIDS
First-ever stroke patients (both sexes, all races, with ages between 15
to 44 years) in the BWCYSS registry were screened as possible
AIDS cases using the following characteristics: ICD-9-CM codes for
HIV infection or other AIDS-associated illness defined in the 1987
AIDS case definition,9,10 a blood test positive for HIV, intravenous
drug abuse identified by history or admission physical examination
findings, low white blood count (3000) at admission, low platelets
(100 000) at admission, and suggestive findings in a narrative
description of “other medical problems.” For all stroke patients who
met the above criteria, the narrative summaries and written descrip-
tions of other medical problems were reviewed, and patients were
classified in accordance with the 1987 Centers for Disease Control
and Prevention (CDC) definition for AIDS.10 Patients with HIV
infection who did not fulfill the criterion for AIDS were included in
the non-AIDS group. Of note, this study was performed in the era
before highly active antiretroviral therapy (HAART); therefore,
AIDS patient were treated, at most, with zidovudine (AZT).
Identification of Strokes Caused by AIDS-Related
Medical Conditions or Other
Concomitant Etiologies
Each case was critically reviewed for AIDS-related medical condi-
tions or other concomitant etiologies. Radiological studies were
analyzed for findings considered atypical for brain-related ischemia
or hemorrhage. This review sought to identify AIDS patients with
stroke in whom other known stroke etiologies existed, including
endocarditis, and/or intracerebral AIDS-related pathologies, includ-
ing opportunistic infections, primary central nervous system lym-
phoma, metastatic Kaposi sarcoma, meningoencephalitis, progres-
sive multifocal leukoencephalopathy, cerebral abscess, and
tuberculoma. These individuals were then excluded from the AIDS
case group during secondary analysis. This procedure was performed
to quantify the effect of AIDS on the risk of stroke exclusive of the
effects of AIDS-related causes of stroke and other stroke etiologies.
Determination of Person-Time at Risk
Law mandates physician reporting of AIDS cases. Data on AIDS
cases residing in the study region were obtained from both the
District of Columbia and the State of Maryland. The data for
Washington was provided by the Agency for HIV/AIDS, Commis-
sion of Public Health, Department of Human Services of the
Government of the District of Columbia through the CDC HIV/
AIDS Reporting System (HARS). New cases were sent to the CDC
to be checked for duplication against confidential identifiers of
name, address, and date of birth to prevent overreporting and to
determine residence history. The CDC then returned the corrected
numbers to the agency.9
For the appropriate Maryland counties, data were provided by the
AIDS Administration of the Maryland Department of Health and
Mental Hygiene, which maintains its own AIDS Registry. Maryland
also uses the HARS system and checks all new records through the
CDC.
The person-time at risk for stroke among AIDS cases was
estimated as the simple average of the number of AIDS cases alive
at the beginning of each study year and the number of AIDS cases
alive at the end of each study year. The person-time at risk for stroke
among persons without AIDS was estimated by subtracting the
person-time calculated for AIDS exposure from the total person-time
in the study population.
We determined the distribution of the population according to sex,
age, and race on the basis of estimates for 1988 and 1991 for the
region of Maryland under study11,12 and on the basis of the 1990 US
census for Washington.13 Persons were categorized according to sex,
10-year age groups, and 2 racial categories (white and all other). The
“all other” category was 86% black.
Statistical Analysis
The incidence of stroke was determined by dividing the number of
strokes by the number of years of person-time for both the AIDS and
non-AIDS populations. The crude relative risks of AIDS as a risk
factor for each stroke was calculated as the ratio of the incidence
rates; the non-AIDS stroke population served as the reference group.
Relative risks adjusted for age, sex, and race and 95% confidence
intervals (CIs) were obtained by fitting Poisson regression models
that predicted the incidence of stroke according to age, sex, race and
whether the person had AIDS.
To assess the statistical differences in demographic characteristics
and risk factors between stroke patients with AIDS and stroke
patients without AIDS, we used Student’s t test for age and Fisher’s
exact test for all other factors. Two-tailed probability values are
reported.
Results
Analysis of All Strokes Among AIDS Versus
Non-AIDS Patients
Within the BWCYSS, there were 386 ischemic stroke (IS)
cases (6 with AIDS) and 171 ICH cases (6 with AIDS).
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Among the 557 stroke patients included, only 2.2% had
AIDS. There were 380 cerebral infarctions and 165 ICHs
during 4 104 734 non–AIDS-exposed person-years. During
the 2829 person-years of AIDS exposure in the study popu-
lation, there were 6 ISs and 6 ICHs. Table 1 lists these cases
by stroke type, general demographic data (sex, age, race),
known risk factors for AIDS, previous medical history, risk
factors for stroke, clinical stroke syndrome, and infarction
location per imaging.
Tables 2 and 3 summarize the demographic and risk factor
data for IS and ICH cases, respectively, with patients cate-
gorized according to their AIDS or non-AIDS status. Stroke
risk factors included in the analysis were history of hyper-
tension, diabetes mellitus, elevated cholesterol, and ischemic
heart disease; current cigarette use; current illicit drug use;
and alcohol abuse. Although there were no statistically
significant differences for these factors between AIDS and
non-AIDS patients for either IS or ICH, non-AIDS cases had
a greater prevalence of vascular risk factors.
Table 4 shows the crude and age-, race-, and sex-adjusted
relative risks for both IS and ICH strokes among all AIDS
patients within the BWCYSS. The incidences of IS and ICH
among persons with AIDS were each 0.2% per year. The
adjusted relative risk for both stroke types was high, 13.7 for
cerebral infarction (95% CI, 6.1 to 30.8) and 25.5 for ICH
(95% CI, 11.2 to 58.0). The combined adjusted relative risk
was 17.8 (95% CI, 10.0 to 31.6).
Analysis of Stroke Cases Excluding Strokes
Caused by AIDS-Related Medical Conditions or
Other Concomitant Etiologies
The 12 strokes among AIDS patients were reviewed for both
AIDS-related causes of stroke and other possible concomitant
causes of stroke. This review revealed 2 cases in the IS group
and 3 cases in the ICH group that were consistent with the
stated exclusion criteria. Among the IS cases, 1 patient
(patient 3) was found to have brain MRI findings that were
read as “unusual for pure ischemia,” and other AIDS-related
pathologies were suggested. The second IS patient (patient 5)
was found to have been admitted in sickle cell crisis with a
markedly depressed hematocrit of 21.6. Among the ICH
cases, 1 patient (patient 8) was found to have a large
pericardial effusion with an increased echogenicity in the area
of the aortic valve in which a vegetation could not be
excluded. The second case (patient 9) excluded was a
hemodialysis patient who received streptokinase to open an
occluded imbedded catheter the day before developing bilat-
eral multifocal ICH. The third ICH case (patient 11) involved
a known intravenous drug abuser. The patient had a positive
blood culture for Staphylococcus aureus with head CT
showing bilateral involvement consistent with an embolic
phenomenon, including a left parietal ICH with abnormalities
also reported in the right parietal lobe.
Table 5 reports the crude and age-, race-, and sex-adjusted
relative risks for both IS and ICH strokes among the AIDS
patients after exclusion of the 5 cases found to have AIDS-
related medical conditions or other concomitant etiologies for
stroke. The incidence of IS and ICH among persons with
AIDS was 0.14% and 0.11% per year for IS and ICH,
respectively. The adjusted relative risk for both stroke types
was high, 9.1 for cerebral infarction (95% CI, 3.4 to 24.6) and
12.7 for ICH (95% CI, 4.0 to 40.0). The combined adjusted
relative risk was 10.4 (95% CI, 4.9 to 22.0).
Discussion
Our results demonstrate that AIDS is strongly associated with
both IS and ICH. Although we were unable to find any
epidemiological studies quantifying the degree of stroke risk
in AIDS patients, several studies suggest potential mecha-
nisms for such a risk. Of 183 cases within the Edinburgh HIV
Autopsy Cohort, an intensive screening procedure identified
10 cases of cerebral infarction that had no evidence of
opportunistic cerebral infection, lymphoma, hemorrhage,
traumatic injury, or potential sources of emboli.3 Detailed
histological examination revealed small-vessel thickening in
all 10 cases, with some cases demonstrating perivascular
space dilation, rarefaction, and pigment deposition, with
vessel wall mineralization and perivascular cell infiltrates but
no evidence of vasculitis. These histopathologic findings
were seen regardless of drug use, hepatitis serology, or
syphilis serology. An HIV-associated vasculopathy was pro-
posed. In South Africa, where intravenous drug use is less
commonly associated with HIV infection, analysis of data
from the Durban Stroke Data Bank showed the percentage of
cryptogenic strokes, based on Trial of Org 10172 in Acute
Stroke Treatment (TOAST) classification, was higher (91%)
among young adult stroke patients with HIV infection than
among age- and sex-matched stroke patients without HIV
infection (36%).2 Available angiographic investigations
showed no evidence of vasculitis. These findings support the
possibility of an intrinsic predisposition to stroke among
HIV-infected patients. A transcranial Doppler study com-
pared HIV-infected patients and healthy control subjects.
Patients with preexisting stenotic or occlusive lesions were
excluded. HIV-infected patients had reduced baseline cere-
bral blood flow and decreased cerebrovascular reserve capac-
ity in response to acetazolamide challenge, suggesting altered
vasoreactive responses in HIV infection.4
Except for studies based on both clinical and pathological
evidence, it is quite difficult to isolate strokes caused by
intrinsic AIDS-associated pathophysiology in the absence of
AIDS-related medical complications or other concomitant
etiologies. Any clinical approach to this issue is fraught with
difficulties. Nevertheless, the implications of our findings
would differ if the excess risk of stroke in AIDS patients were
due to endocarditis or nonvascular AIDS-related intracranial
pathology. Thus, we performed a secondary analysis, exclud-
ing patients with other concomitant etiologies. Of note, no
brain biopsy or autopsy data were available. Despite a
reasonable approach to these exclusions, AIDS infection was
still strongly associated with stroke.
Our study possesses other limitations and sources of
potential bias. One limitation is the small number of AIDS
cases among women. Only 2 of 12 strokes cases with AIDS,
1 IS and 1 ICH, occurred among women. Similarly, only 10%
of the reported AIDS cases in our study area were women.
For these reasons, our study findings may not be generaliz-
able to women. However, if women are excluded from
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 by guest on December 20, 2012http://stroke.ahajournals.org/Downloaded from 
TABLE 1. Demographics, Risk Factors, Clinical Syndrome, Testing, and Etiology Among AIDS Patients With IS and ICH Within the
Young Stroke Data Bank
Patient
Stroke
Type Sex
Age,
y Race
Risk Factors
for AIDS
Previous Medical
History
Risk Factors
for Stroke
Clinical Stroke
Syndrome
Stroke Location per
Imaging
1 IS M 40 Black IVDA PCP Alcohol abuse R hemiparesis L IC lacune
Anemia DM
Leucopenia HTN
AZT therapy
2 IS M 37 Black IVDA Splenectomy Cocaine abuse Aphasia L parietal involving
Thrombocytopenia R facial palsy L basal ganglia
Polyclonal gammopathy R hemiparesis
Herpes zoster infection
3 IS M 43 Black IVDA Alcohol abuse Vertebrobasilar L thalamus
DM syndrome with L occipital
High cholesterol dizziness, L cerebellum
HTN dysphagia, and (Pattern unusual
Smoking ataxia for pure ischemia)*
4 IS M 27 Black Homosexual CMV pneumonia None Slurred speech R fronto parietal
L-sided ataxia R basal ganglia
R caudate
5 IS M 32 Black IVDA Thrombocytopenia Alcohol abuse R hemiparesis L basal ganglia
Transfusion Herpes zoster infection Sickle cell R hemisensory
TB–treated disease/crisis* deficit
6 IS F 33 Black Transfusion Chronic candidiasis DM Slurred speech R parietal-occipital
Aplastic anemia Smoking L homonymous R cerebellum
Hemianopsia R parietal
L hemiparesis R centrum semiovale
7 ICH M 36 Black IVDA AIDS dementia Unknown Lethargy L frontal/parietal/
AZT therapy R hemiparesis temporal
PCP
8 ICH M 35 Black IVDA Thrombocytopenia DM Coma L parietal
Herpes zoster infection HTN cisternal and
AZT therapy Smoking intraventricular
Bacterial endocarditis Bacterial
endocarditis*
9 ICH F 33 Black IVDA Neurosyphilis–treated, Cocaine abuse Lethargy R parietal/occipital
with FTA positive DM R hemiparesis L frontal
and RPR negative High cholesterol
HTN
Smoking
Recent tx with
streptokinase*
10 ICH M 36 Black Unknown Kaposi’s sarcoma High cholesterol R hemiparesis L frontal/parietal
PCP Smoking and SAH
Hepatic failure
Thrombocytopenia
11 ICH M 36 Black IVDA AZT therapy Alcohol abuse Seizures L parietal/occipital
Homosexual Thrombocytopenia DM Coma R parietal
transfusion Cirrhosis High cholesterol
HTN
Smoking
Staphylococcus aureus
in blood culture*
12 ICH M 30 White Transfusion PCP DM Lethargy L frontal/parietal
CMV retinitis High cholesterol R hemiparesis and SAH
Thrombocytopenia HTN
Hepatitis Smoking
IVDA indicates intravenous drug abuse; PCP, pneumocystis carinii pneumonia; HTN, hypertension; DM, diabetes mellitus; IC, internal capsule; CMV, cytomegalovirus;
TB, tuberculosis; FTA, free treponemal antibody; and RPR, rapid plasma reagin.
*Case was removed from secondary analysis.
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analysis, the relative risk of AIDS does not change apprecia-
bly. The recalculated crude relative risks excluding females
are 21.5 for cerebral infarction (95% CI, 6.9 to 51.2) and 39.2
for ICH (95% CI, 12.5 to 94.7).
A potential source of bias is the possibility of underreport-
ing of AIDS cases in the population under study, which
would underestimate the person-time at risk for stroke among
AIDS patients and inflate the relative risk associated with
AIDS. Available data suggest a high degree of completeness
for the CDC AIDS surveillance in the study region during the
years of this study. A national study reported a completeness
of 92% for 1988,14 and internal analyses by the Maryland
AIDS Registry reported a completeness of 94% for 1991
(personal communication). These evaluations of the reporting
rate relied on hospitalization records. Therefore, to the extent
that AIDS patients did not receive any hospital inpatient care,
the number of cases could be underestimated. Nevertheless,
we believe it is unlikely that the magnitude of the underre-
porting of AIDS cases in the study population would appre-
ciably alter our results. It is also possible that we did not
identify every AIDS patient among our stroke cases. Addi-
tionally, some AIDS patients with stroke may not have
received ICD-9 codes for stroke at discharge because of a
large number of other important medical problems. Both of
these circumstances would lead to an underascertainment of
AIDS patients with stroke, which would tend to underesti-
mate the association between AIDS and stroke.
Because of the design of our study, it was not possible to
adjust relative risks for factors other than age, race, and sex.
However, the prevalence of hypertension, diabetes mellitus,
and cigarette smoking was lower among AIDS patients with
stroke than among stroke patients without AIDS or in the
general population, according to data from the Maryland
Behavioral Risk Factor Survey for the same region during the
same years.15 Thus, adjustment for these factors would have
produced a stronger association between AIDS and stroke.
Our study was conducted in the pre-HAART era, although
4 of our patients were on AZT therapy, as indicated in Table
1. Therefore, our findings are relevant to most AIDS patients
worldwide who do not have access to HAART therapy. In
addition, our study provides an excellent baseline for the
stroke risk of AIDS, which will allow comparison to future
studies of stroke risk in the era of HAART therapy.
One strength of our study was that only patients who met
the strict 1987 CDC AIDS definition10 were included in the
exposed group. Thus, 10 HIV-positive patients in the IS
group and 5 HIV-positive patients in the ICH group were
included in the non-AIDS stroke group. If these HIV-positive
patients were more comparable to AIDS patients in terms of
stroke risk, then this would have tended to decrease the
observed association between stroke and AIDS.
In conclusion, this is the first population-based study to
directly quantify the AIDS-associated risk of stroke. We also
attempted to address the possibility that pathophysiological
mechanisms intrinsic to AIDS may predispose to stroke. Even
TABLE 4. Crude and Adjusted Relative Risk of Stroke for All
AIDS Cases
Crude
Relative
Risk
95%
CI
Adjusted*
Relative
Risk
95%
CI
IS relative risk 23.0 8.4–50.4 13.7 6.1–30.8
ICH relative risk 52.9 19.1–117.6 25.5 11.2–58.0
Either type of stroke
relative risk
32.0 16.4–56.3 17.8 10.0–31.6
*Age-, sex-, and race-adjusted.
TABLE 5. Crude/Adjusted Relative Risk of Stroke Excluding
Strokes Caused by AIDS-Related Medical Conditions or Other
Concomitant Etiologies
Crude
Relative
Risk
95%
CI
Age-, Race-,
Sex-Adjusted
Relative Risk
95%
CI
IS relative risk 15.3 4.1–39.5 9.1 3.4–24.6
ICH relative risk 26.4 5.4–78.6 12.7 4.0–40.0
Either type of stroke
relative risk
18.6 7.5–38.7 10.4 4.9–22.0
TABLE 2. Risk Factor Comparison for IS
Risk Factor
IS
AIDS
Patients
(n6)
Non-AIDS
Patients
(n380)
2-Tailed
P
Mean age, y 35.3 36.4
Male, % 83 70 0.115
Nonwhite, % 100 44 0.671
Hypertension, % 16 48 0.218
Diabetes mellitus, % 16 20 1.0
Elevated cholesterol, % 17 41 0.408
Ischemic heart disease, % 0 8 1.0
Current Cigarette Use, % 33 47 0.690
Current illicit drug use, % 50 22 0.135
Alcohol abuse, % 33 21 0.608
TABLE 3. Risk Factor Comparison for ICH
Risk Factor
ICH
AIDS
Patients
(n6)
Non-AIDS
Patients
(n165)
2-Tailed
P
Mean age, y 34.5 36.1
Male, % 83 76 0.410
Nonwhite, % 83 58 1.0
Hypertension, %* 25 52 0.36
Diabetes mellitus, %* 0 5 1.0
Elevated cholesterol, %* 50 28 0.575
Ischemic heart disease, %* 0 3 1.0
Current cigarette use, %* 0 23 0.572
Current illicit drug use, %* 75 38 0.296
Alcohol abuse, %* 0 30 0.318
*Only ICHs occurring in 1991 were compared (4 AIDS cases, 79 non-AIDS
cases).
Cole et al Acquired Immunodeficiency Syndrome and Stroke Risk 55
 by guest on December 20, 2012http://stroke.ahajournals.org/Downloaded from 
after exclusion of 42% of our cases potentially attributable to
other known causes or complications of AIDS, there was a
strong association between AIDS and both IS and ICH.
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